FDG for dose painting: A rational choice

This publication has 32 references indexed in Scilit:

• Hypoxic Tumor Microenvironment and Cancer Cell Differentiation
  Current Molecular Medicine, 2009
• [18F]EF3 is not superior to [18F]FMISO for PET-based hypoxia evaluation as measured in a rat rhabdomyosarcoma tumour model
  European Journal of Nuclear Medicine and Molecular Imaging, 2008
• Hypoxia Dose Painting by Numbers: A Planning Study
  International Journal of Radiation Oncology*Biology*Physics, 2007
• Kinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer
  BMC Cancer, 2005
• Randomized Phase III Trial of Sequential Chemoradiotherapy Compared With Concurrent Chemoradiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique–Groupe Français de Pneumo-Cancérologie NPC 95-01 Study
  Journal of Clinical Oncology, 2005
• A Review of Radiation Dose Escalation Trials for Non-Small Cell Lung Cancer Within the Radiation Therapy Oncology Group
  Seminars in Oncology, 2005
• Theragnostic imaging for radiation oncology: dose-painting by numbers
  The Lancet Oncology, 2005
• Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study
  Lung Cancer, 2004
• Dose Escalation in Non–Small-Cell Lung Cancer Using Three-Dimensional Conformal Radiation Therapy: Update of a Phase I Trial
  Journal of Clinical Oncology, 2001
• Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non–Small-Cell Lung Cancer
  Journal of Clinical Oncology, 1999